AXL receptor tyrosine kinase, whose expression is associated with stem-like properties, up-regulation of DNA repair genes and resistance to DNA damaging agents in many cancer types [102,103,104,105,106], has also been reported to be overexpressed in some MAPKi-resistant melanoma cells [88,107]. The gene discussed is AXL; the disease is cancer.